Back to Explorer
AI for drug design
Hong Kong
Founded 2014
600 employees
$407.0M raised
Funding & Financials
Total Funding
$407.0M
Last Round
Series D
Last Round Size
$95.0M
Company Type
private
Last Round Date
2024-01
Investors
Warburg PincusB CapitalLilly Asia Ventures
Notes
Generative chemistry
Strategic Scores
Thesis Fit8/10
Alignment with key investment themes
Overcrowded7/10
Category density relative to landscape
Strategic Importance6/10
Layer importance, uniqueness, maturity
Stack Position
Layer
Application
Category
Vertical AI
Subcategory
Drug Discovery